Rivus Pharmaceuticals

👥 12 employees💰 Last funded Mar 2019
Biotechnology Research🌐 rivuspharma.com
Website LinkedIn
Rivus Pharmaceuticals, Inc., is dedicated to transforming the treatment of cardio-metabolic disease by advancing a new class of oral, once daily, small molecule therapeutics called Controlled Metabolic Accelerators (CMAs). Rivus’ CMAs are designed to improve cellular metabolism and treat the underlying cause of highly prevalent metabolic and cardiovascular diseases including type 2 diabetes, severe hypertriglyceridemia (SHTG), non-alcoholic steatohepatitis (NASH), as well as cardiovascular diseases such as heart failure with reduced ejection fraction (HFpEF). For more information please visit https://www.rivuspharma.com/
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Rivus Pharmaceuticals?
Rivus Pharmaceuticals has 1 investors on record on gritt.io.
When did Rivus Pharmaceuticals last raise funding?
The most recent investment in Rivus Pharmaceuticals recorded on gritt.io was in March 2019.
What industry is Rivus Pharmaceuticals in?
Rivus Pharmaceuticals operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.